120 related articles for article (PubMed ID: 25991504)
1. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.
Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon YD; Harsum S; MacLaren RE; Charteris DG; Van Meurs JC; González-Sarmiento R; Pastor JC;
Acta Ophthalmol; 2015 Nov; 93(7):e541-9. PubMed ID: 25991504
[TBL] [Abstract][Full Text] [Related]
2. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.
Pastor-Idoate S; Rodriguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; van Meurs J; González-Sarmiento R; Pastor JC;
Ophthalmology; 2013 Mar; 120(3):623-628. PubMed ID: 23207172
[TBL] [Abstract][Full Text] [Related]
3. BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.
Moschos MM; Chatziralli I; Brouzas D; Gazouli M
Ophthalmic Res; 2017; 58(4):227-230. PubMed ID: 28877516
[TBL] [Abstract][Full Text] [Related]
4. ASSOCIATION STUDY BETWEEN POLYMORPHISMS OF THE p53 AND LYMPHOTOXIN ALPHA (LTA) GENES AND THE RISK OF PROLIFERATIVE VITREORETINOPATHY/RETINAL DETACHMENT IN A MEXICAN POPULATION.
Quiroz-Casian N; Lozano-Giral D; Miranda-Duarte A; Garcia-Montalvo I; Rodriguez-Loaiza JL; Zenteno JC
Retina; 2018 Jan; 38(1):187-191. PubMed ID: 28106707
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study.
Sanabria Ruiz-Colmenares MR; Pastor Jimeno JC; Garrote Adrados JA; Telleria Orriols JJ; Yugueros Fernández MI
Acta Ophthalmol Scand; 2006 Jun; 84(3):309-13. PubMed ID: 16704689
[TBL] [Abstract][Full Text] [Related]
6. A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.
Rojas J; Fernandez I; Pastor JC; Maclaren RE; Ramkissoon Y; Harsum S; Charteris DG; Van Meurs JC; Amarakoon S; Ruiz-Moreno JM; Rocha-Sousa A; Brion M; Carracedo A;
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1665-78. PubMed ID: 23258148
[TBL] [Abstract][Full Text] [Related]
7. Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.
Rojas J; Fernandez I; Pastor JC; MacLaren RE; Ramkissoon Y; Harsum S; Charteris DG; Van Meurs JC; Amarakoon S; Garcia-Arumi J; Ruiz-Moreno JM; Rocha-Sousa A; Brion M; Carracedo A;
Br J Ophthalmol; 2015 Jan; 99(1):41-8. PubMed ID: 25075124
[TBL] [Abstract][Full Text] [Related]
8. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutiérrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; VanMeurs JC; González-Sarmiento R; Pastor JC;
PLoS One; 2013; 8(12):e82283. PubMed ID: 24349246
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia.
Fernandes AT; Rocha NP; Vendrame E; Russomano F; Grinsztejn BJ; Friedman RK; Pinto AC; Klumb EM; Avvad E; Macedo J; Martínez-Maza O; Bonecini-Almeida Mda G
Apoptosis; 2015 Oct; 20(10):1347-57. PubMed ID: 26272263
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and Oxidative Stress Gene Variability in Retinal Detachment Patients with and without Proliferative Vitreoretinopathy.
Lumi X; Confalonieri F; Ravnik-Glavač M; Goričar K; Blagus T; Dolžan V; Petrovski G; Hawlina M; Glavač D
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107562
[TBL] [Abstract][Full Text] [Related]
11. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
12. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
[TBL] [Abstract][Full Text] [Related]
13. SINGLE NUCLEOTIDE POLYMORPHISMS IN RETINAL DETACHMENT PATIENTS WITH AND WITHOUT PROLIFERATIVE VITREORETINOPATHY.
Lumi X; Jelen MM; Zupan A; Boštjančič E; Ravnik-Glavač M; Hawlina M; Glavač D
Retina; 2020 May; 40(5):811-818. PubMed ID: 30807515
[TBL] [Abstract][Full Text] [Related]
14. Effects of lysyl oxidase genetic variants on the susceptibility to rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Yu H; Li T; Zou X; Yuan L; Hu J; Xu Z; Peng L; Zhang C; Zou Y
Inflammation; 2013 Aug; 36(4):839-44. PubMed ID: 23413043
[TBL] [Abstract][Full Text] [Related]
15. The role of thrombin in proliferative vitreoretinopathy.
Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
[TBL] [Abstract][Full Text] [Related]
16. A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: the retina 4 project.
Rojas J; Fernandez I; Pastor JC; Garcia-Gutierrez MT; Sanabria MR; Brion M; Coco RM; Ruiz-Moreno JM; Garcia-Arumi J; Elizalde J; Ruiz-Miguel M; Gallardo JM; Corrales RM; Carracedo A
Ophthalmology; 2010 Dec; 117(12):2417-2423.e1-2. PubMed ID: 20663564
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.
Storey P; Alshareef R; Khuthaila M; London N; Leiby B; DeCroos C; Kaiser R;
Retina; 2014 Oct; 34(10):1945-51. PubMed ID: 24999720
[TBL] [Abstract][Full Text] [Related]
18. Development of predictive models of proliferative vitreoretinopathy based on genetic variables: the Retina 4 project.
Rojas J; Fernandez I; Pastor JC; Garcia-Gutierrez MT; Sanabria RM; Brion M; Sobrino B; Manzanas L; Giraldo A; Rodriguez-de la Rua E; Carracedo A
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2384-90. PubMed ID: 19098314
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of
Al-Zubaidy HFS; Majeed SR; Al-Koofee DAF
Arch Razi Inst; 2022 Apr; 77(2):799-808. PubMed ID: 36284943
[TBL] [Abstract][Full Text] [Related]
20. Conventional retinal surgery for rhegmatogenous retinal detachment with proliferative vitreoretinopathy.
Ivanisević M
Acta Med Croatica; 1995; 49(4-5):207-9. PubMed ID: 8630455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
